COVID-19 Impact on Global T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

September 2020 | 98 pages | ID: C17A6FA37016EN
QYResearch

Abstracts

This report focuses on the global T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Juno Therapeutics
• Kite Pharma
• Novartis
• Takara Bio
• Unum Therapeutics

Market segment by Type, the product can be split into

• CAR-T
• TCR
• TIL Therapies

Market segment by Application, split into

• Stomach Cancer
• Lung Cancer
• Colorectal Cancer
• Esophagus Cancer
• Pancreatic Cancer
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players.
• To present the T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of T-Cell Immunotherapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 CAR-T
  1.4.3 TCR
  1.4.4 TIL Therapies
1.5 Market by Application
  1.5.1 Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
  1.5.2 Stomach Cancer
  1.5.3 Lung Cancer
  1.5.4 Colorectal Cancer
  1.5.5 Esophagus Cancer
  1.5.6 Pancreatic Cancer
  1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): T-Cell Immunotherapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the T-Cell Immunotherapy Industry
    1.6.1.1 T-Cell Immunotherapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for T-Cell Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 T-Cell Immunotherapy Market Perspective (2015-2026)
2.2 T-Cell Immunotherapy Growth Trends by Regions
  2.2.1 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
  2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 T-Cell Immunotherapy Market Growth Strategy
  2.3.6 Primary Interviews with Key T-Cell Immunotherapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top T-Cell Immunotherapy Players by Market Size
  3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2015-2020)
  3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global T-Cell Immunotherapy Market Concentration Ratio
  3.2.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2019
3.3 T-Cell Immunotherapy Key Players Head office and Area Served
3.4 Key Players T-Cell Immunotherapy Product Solution and Service
3.5 Date of Enter into T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)

5 T-CELL IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global T-Cell Immunotherapy Market Size by Application (2015-2020)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America T-Cell Immunotherapy Market Size (2015-2020)
6.2 T-Cell Immunotherapy Key Players in North America (2019-2020)
6.3 North America T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America T-Cell Immunotherapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe T-Cell Immunotherapy Market Size (2015-2020)
7.2 T-Cell Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 Europe T-Cell Immunotherapy Market Size by Application (2015-2020)

8 CHINA

8.1 China T-Cell Immunotherapy Market Size (2015-2020)
8.2 T-Cell Immunotherapy Key Players in China (2019-2020)
8.3 China T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 China T-Cell Immunotherapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan T-Cell Immunotherapy Market Size (2015-2020)
9.2 T-Cell Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 Japan T-Cell Immunotherapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2020)
10.2 T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020)

11 INDIA

11.1 India T-Cell Immunotherapy Market Size (2015-2020)
11.2 T-Cell Immunotherapy Key Players in India (2019-2020)
11.3 India T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 India T-Cell Immunotherapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America T-Cell Immunotherapy Market Size (2015-2020)
12.2 T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America T-Cell Immunotherapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Adaptimmune
  13.1.1 Adaptimmune Company Details
  13.1.2 Adaptimmune Business Overview and Its Total Revenue
  13.1.3 Adaptimmune T-Cell Immunotherapy Introduction
  13.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020))
  13.1.5 Adaptimmune Recent Development
13.2 Altor Bioscience Corporation
  13.2.1 Altor Bioscience Corporation Company Details
  13.2.2 Altor Bioscience Corporation Business Overview and Its Total Revenue
  13.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
  13.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.2.5 Altor Bioscience Corporation Recent Development
13.3 Cellectis
  13.3.1 Cellectis Company Details
  13.3.2 Cellectis Business Overview and Its Total Revenue
  13.3.3 Cellectis T-Cell Immunotherapy Introduction
  13.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.3.5 Cellectis Recent Development
13.4 Juno Therapeutics
  13.4.1 Juno Therapeutics Company Details
  13.4.2 Juno Therapeutics Business Overview and Its Total Revenue
  13.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
  13.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.4.5 Juno Therapeutics Recent Development
13.5 Kite Pharma
  13.5.1 Kite Pharma Company Details
  13.5.2 Kite Pharma Business Overview and Its Total Revenue
  13.5.3 Kite Pharma T-Cell Immunotherapy Introduction
  13.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.5.5 Kite Pharma Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis T-Cell Immunotherapy Introduction
  13.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 Takara Bio
  13.7.1 Takara Bio Company Details
  13.7.2 Takara Bio Business Overview and Its Total Revenue
  13.7.3 Takara Bio T-Cell Immunotherapy Introduction
  13.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.7.5 Takara Bio Recent Development
13.8 Unum Therapeutics
  13.8.1 Unum Therapeutics Company Details
  13.8.2 Unum Therapeutics Business Overview and Its Total Revenue
  13.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
  13.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
  13.8.5 Unum Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. T-Cell Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by T-Cell Immunotherapy Revenue
Table 3. Ranking of Global Top T-Cell Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CAR-T
Table 6. Key Players of TCR
Table 7. Key Players of TIL Therapies
Table 8. COVID-19 Impact Global Market: (Four T-Cell Immunotherapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for T-Cell Immunotherapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for T-Cell Immunotherapy Players to Combat Covid-19 Impact
Table 13. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global T-Cell Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global T-Cell Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global T-Cell Immunotherapy Market Share by Regions (2015-2020)
Table 17. Global T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global T-Cell Immunotherapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. T-Cell Immunotherapy Market Growth Strategy
Table 23. Main Points Interviewed from Key T-Cell Immunotherapy Players
Table 24. Global T-Cell Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global T-Cell Immunotherapy Market Share by Players (2015-2020)
Table 26. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2019)
Table 27. Global T-Cell Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players T-Cell Immunotherapy Product Solution and Service
Table 30. Date of Enter into T-Cell Immunotherapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global T-Cell Immunotherapy Market Size Share by Type (2015-2020)
Table 34. Global T-Cell Immunotherapy Revenue Market Share by Type (2021-2026)
Table 35. Global T-Cell Immunotherapy Market Size Share by Application (2015-2020)
Table 36. Global T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global T-Cell Immunotherapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 40. North America T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 42. North America T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 44. Europe Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 46. Europe T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 48. Europe T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 50. China Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 52. China T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 53. China T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 54. China T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 55. China T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 56. Japan Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 58. Japan T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 60. Japan T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 64. Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 66. Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 68. India Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 70. India T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 71. India T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 72. India T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 73. India T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 76. Central & South America T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 78. Central & South America T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 80. Adaptimmune Company Details
Table 81. Adaptimmune Business Overview
Table 82. Adaptimmune Product
Table 83. Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 84. Adaptimmune Recent Development
Table 85. Altor Bioscience Corporation Company Details
Table 86. Altor Bioscience Corporation Business Overview
Table 87. Altor Bioscience Corporation Product
Table 88. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 89. Altor Bioscience Corporation Recent Development
Table 90. Cellectis Company Details
Table 91. Cellectis Business Overview
Table 92. Cellectis Product
Table 93. Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 94. Cellectis Recent Development
Table 95. Juno Therapeutics Company Details
Table 96. Juno Therapeutics Business Overview
Table 97. Juno Therapeutics Product
Table 98. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 99. Juno Therapeutics Recent Development
Table 100. Kite Pharma Company Details
Table 101. Kite Pharma Business Overview
Table 102. Kite Pharma Product
Table 103. Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 104. Kite Pharma Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Takara Bio Company Details
Table 111. Takara Bio Business Overview
Table 112. Takara Bio Product
Table 113. Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 114. Takara Bio Recent Development
Table 115. Unum Therapeutics Business Overview
Table 116. Unum Therapeutics Product
Table 117. Unum Therapeutics Company Details
Table 118. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 119. Unum Therapeutics Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. CAR-T Features
Figure 3. TCR Features
Figure 4. TIL Therapies Features
Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
Figure 6. Stomach Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Esophagus Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Immunotherapy Report Years Considered
Figure 13. Global T-Cell Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global T-Cell Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 15. Global T-Cell Immunotherapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global T-Cell Immunotherapy Market Share by Players in 2019
Figure 18. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2019
Figure 20. North America T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 29. Altor Bioscience Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 31. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 33. Juno Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 35. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 37. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 39. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 41. Unum Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed